Previous 10 | Next 10 |
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited ret...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal disea...
The following slide deck was published by Applied Genetic Technologies Corporation in conjunction with their 2022 Q4 earnings call. For further details see: Applied Genetic Technologies Corporation 2022 Q4 - Results - Earnings Call Presentation
Applied Genetic Technologies Corporation (AGTC) Q4 2021 Earnings Conference Call September 24, 2021 16:30 ET Company Participants Sue Washer - Chief Executive Officer Jon Lieber - Chief Financial Officer Stephen Potter - Chief Business Officer Matt Feinsod - Executive Vice President, Global C...
Applied Genetic (NASDAQ:AGTC): Q4 GAAP EPS of -$0.28 beats by $0.12. Revenue of $0.5M Press Release Financial Guidance: As of June 30, 2021, the Company's cash, cash equivalents and investments totaled $107.1M. Net loss was $12.1M. Shares +3.2% after hours For furt...
-Data from ongoing clinical trials in XLRP and ACHM shows evidence of clinical activity and tolerability; multiple data readouts expected in 2021 and 2022- -Pre-Clinical programs moving to IND enabling animal studies- -Company adds experienced industry veterans to board and manage...
AEHR, AGTC, AIR, DADA, COST, MTN, NKE, PRGS, TCOM For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Thursday's close
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal disea...
AGTC, FCEL For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Tuesday's open
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited ret...
News, Short Squeeze, Breakout and More Instantly...
Applied Genetic Technologies Corporation Company Name:
AGTC Stock Symbol:
NASDAQ Market:
Applied Genetic Technologies Corporation Website:
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”) has exte...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purcha...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purcha...